Clinical trial Recruiting at 1 site Observational Ages 18 and up

Analyzing exhaled breath patterns in patients with pulmonary diseases

Official title: Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Human Subjects

Run by University of Zurich · NCT05456009 · Data updated 2026-11-12

This study is trying to see how breathing patterns change in adults with obstructive sleep apnea or other lung diseases after taking medication.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedFebruary 19, 2019
Main results expectedMarch 1, 2030
Study endsMarch 1, 2030
Registry record updatedMay 29, 2026
Trial IDNCT05456009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with obstructive sleep apnea or other pulmonary diseases.

Probably not a fit

Patients who are under 18 years old or unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on identifying exhaled breath patterns in human subjects, particularly those with obstructive sleep apnea (OSA) or other pulmonary diseases. Utilizing mass spectrometry, the study aims to analyze breath samples in a non-invasive manner to gather data on how medication intake affects these patterns. The research will involve adult participants who provide informed consent, with specific exclusion criteria for certain subgroups. The findings could enhance understanding of respiratory conditions and their management.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods for pulmonary diseases based on breath analysis.

How similar studies have gone: While breath analysis is a growing field, this specific approach using mass spectrometry in the context of OSA and pulmonary diseases is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \>= 18 years
* Informed consent

Exclusion Criteria:

* specific exclusion criteria for different subgroups

Where it's running

  • University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.